Suzanne E. Fenton

Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Cancer and developmental exposure to endocrine disruptors.

A novel effect of dioxin: exposure during pregnancy severely impairs mammary gland differentiation.

Exposure parameters necessary for delayed puberty and mammary gland development in Long-Evans rats exposed in utero to atrazine.

Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth.

Collection and use of exposure data from human milk biomonitoring in the United States.

Conclusions and recommendations of the expert panel: technical workshop on human milk surveillance and biomonitoring for environmental chemicals in the United States.

A mixture of ammonium perchlorate and sodium chlorate enhances alterations of the pituitary-thyroid axis caused by the individual chemicals in adult male F344 rats.

Altered mammary gland development in male rats exposed to genistein and methoxychlor.

Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences.

Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures.

Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring.

Gestational exposure to nonylphenol causes precocious mammary gland development in female rat offspring.

Atrazine-induced reproductive tract alterations after transplacental and/or lactational exposure in male Long-Evans rats.

Mammary gland development as a sensitive end point after acute prenatal exposure to an atrazine metabolite mixture in female Long-Evans rats.

Assays for endogenous components of human milk: comparison of fresh and frozen samples and corresponding analytes in serum.

Analysis of PFOA in dosed CD1 mice. Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups.

Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures.

Concentrations of phthalate metabolites in milk, urine, saliva, and Serum of lactating North Carolina women.

Human milk biomonitoring of phthalates: expanding our understanding of infant exposure is compatible with supporting breastfeeding.

Polyfluoroalkyl chemicals in the serum and milk of breastfeeding women.

Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups.

Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life.

Developmental exposure to a commercial PBDE mixture, DE-71: neurobehavioral, hormonal, and reproductive effects.

The mammary gland: a tissue sensitive to environmental exposures.

Aryl hydrocarbon receptor activation during pregnancy, and in adult nulliparous mice, delays the subsequent development of DMBA-induced mammary tumors.

Effects of prenatal exposure to a low dose atrazine metabolite mixture on pubertal timing and prostate development of male Long-Evans rats.

Endocrine disrupting properties of perfluorooctanoic acid.

Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry.

Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice.

Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations.

Developmental toxicology: new directions workshop: refining testing strategies and study designs.

Perinatal environmental exposures affect mammary development, function, and cancer risk in adulthood.

Histopathologic changes in the uterus, cervix and vagina of immature CD-1 mice exposed to low doses of perfluorooctanoic acid (PFOA) in a uterotrophic assay.

Researching chemicals in human milk can be conducted without discouraging breastfeeding.

Endocrine disruptors and the breast: early life effects and later life disease.

Exposure to diethylstilbestrol during sensitive life stages: a legacy of heritable health effects.

Improving the risk assessment of lipophilic persistent environmental chemicals in breast milk.

Hepatic Mitochondrial Alteration in CD-1 Mice Associated with Prenatal Exposures to Low Doses of Perfluorooctanoic Acid (PFOA).

Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.

Concentrations of environmental phenols and parabens in milk, urine and serum of lactating North Carolina women.

Application of Sholl analysis to quantify changes in growth and development in rat mammary gland whole mounts.

The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure.

Essential role of Orai1 store-operated calcium channels in lactation.

A special issue dedicated to a complex tissue.

Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation.

Timing of Environmental Exposures as a Critical Element in Breast Cancer Risk.

Polybrominated Diphenyl Ethers in Human Milk and Serum from the U.S. EPA MAMA Study: Modeled Predictions of Infant Exposure and Considerations for Risk Assessment.

Preparation of High-quality Hematoxylin and Eosin-stained Sections from Rodent Mammary Gland Whole Mounts for Histopathologic Review.

Differences in the Rate of in Situ Mammary Gland Development and Other Developmental Endpoints in Three Strains of Female Rat Commonly Used in Mammary Carcinogenesis Studies: Implications for Timing of Carcinogen Exposure.

Mammary Gland Evaluation in Juvenile Toxicity Studies: Temporal Developmental Patterns in the Male and Female Harlan Sprague-Dawley Rat.

Gestational exposure to perfluorooctanoic acid (PFOA): Alterations in motor related behaviors.

Effects of perfluorinated chemicals on thyroid function, markers of ovarian reserve, and natural fertility.